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Abstract
We present a symptomatic 40-year-old cirrhotic man who presented with sudden onsets of syncope.
Echocardiography revealed right ventricular outflow track obstruction caused by a huge right atrial mass. The
tumor was surgically excised under cardiopulmonary bypass. Although no primary cancerous lesion in the liver was
detected, histopathology revealed that the mass was a metastatic hepatocellular carcinoma. The aim of this report
is to show the value of urgent preoperative computed tomography and its contribution in the operative strategy.
The importance of urgent surgical treatment with tricuspid valve sparing tumor resection is emphasized even
though the prognosis for such patients is dismal. We also discuss the further management options of such rare
cases
Background
Hepatocellular metastatic carcinomas to the heart are
uncommon malignant tumors that are usually located to
the right atrium. Prompt diagnosis of their presence is
of major clinical importance because although rare they
can cause obstructive phenomena, heart failure and even
sudden cardiac death [1-3]. Herein, we present a patient
with a metastatic hepatocellular carcinoma located in
the right atrium and invading the right ventricle, the pre
op workout and the subsequent management
Case report
A 40 year old cirrhotic male was admitted to the cardi-
ology emergency department due to sudden onsets of
syncope. He also presented with exertional dyspnoea
accompanied by continuous chest pain and cough. His
medical history included hepatitis B marker positive.
Clinical examination revealed cyanotic and swollen head
and neck with distended jugular veins up to the angle of
the mandible. His blood pressure was 98/62 mmHg and
the oxygen saturation on room air was 90%. Cardiac
rhythm was normal but the rate was increased. Electro-
cardiogram (ECG) showed sinus tachycardia (145 beats/
min). Urgent cardiac ultrasound revealed a giant mass
that partially occupied the right atrium. A subsequent
urgent chest CT angiography presented a huge non-
homogenous tumour occupying almost the entire right
atrium and partially invading the right ventricle. The
CT showed no liver tumour or other subdiaphragmatic
tumour extension. (Figure 1)
The patient underwent urgent surgical treatment due
to worsening of his clinical condition. The findings of
the CT guided our surgical strategy as follows: Initially
femoro-femoral cannulation was installed in order to
commence cardiopulmonary bypass (CPB). Thus the
pericardial cavity could be approached with safety. After
median sternotomy, the superior vena cava was also
cannulated and transfixed and then antegrade cardiople-
gia was administered. The heart was cooled down to 30°
C, the right atrium was incised and the large tumor was
c a r e f u l l ya n dc o p i o u s l yd i s s e c t e df r o mt h es u r r o u n d i n g
tissues due to its friability. (Figure 2) The tumor origi-
nated mostly from the inferior vena cava and its term-
inal end was inside the right ventricle. The tricuspid
valve was also invaded. The tumor was removed using a
valve sparing technique. It was cautiously dissected from
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dium ensuring that no remnants were left behind both
on the tricuspid valvular cusps and within the vicinity of
the right ventricle. The specimen was histopathologically
investigated and eventually diagnosed as a metastatic
hepatocellular carcinoma (HCC). (Figure 3)
Recovery was uneventful. Follow up echocardiography
and cardiac MRI two months after surgery did not
demonstrate any tumor recurrence or tricuspid regurgi-
tation. Additionally PET CT and abdominal MRI
showed no primary hepatoma or metastasis elsewhere in
the body. No further adjuvant therapy was considered
necessary in this stage by our consulting oncologists.
The patient was suggested to be under closed follow-up
with radiology studies (MRI, CT, and PET) in order to
promptly detect solitary masses might be respectable
but unfortunately he refused any other treatment option
and returned to his country.
Discussion
Primary liver cancer is the fifth most common neoplasm
with an incidence of 5.5-14.9% of all tumours. Predis-
posing factors for orthotopic primary Hepatocellular
Carcinoma (HCC) generation are chronic hepatitis B or
C, infection and cirrhosis secondary to other chronic
liver disease. Worldwide, the majority of patients with
HCC have underlying cirrhosis, and it is uncommon to
find HCC in patients without cirrhosis. Among rare
cases with HCC without underlying cirrhosis, HCV
infection accounted for 3-54%, HBV infection for 4-29%,
and heavy alcohol intake for 0-28% [1]. Although HCC
has a very aggressive metastatic profile, its tendency to
spread towards the heart is unusual but well documen-
ted through several published case reports which define
an incidence of cardiac metastasis at 0.67-3% [2,3].
However very few cases of giant metastatic HCC within
the right cardiac cavities that cause significant occlusion
of the tricuspid valve are described in the current
literature.
Therefore an interesting feature of HCC can be its
varied and sometimes bizarre presentation [4]. This
report describes an unusual presentation of HCC. The
patient appeared with symptoms of acute heart failure
caused by a giant right atrial malignant obstructive
hepatocellular mass without any detectable cancerous
lesions in the liver. There was no radiological, clinical or
laboratory suspicion of HCC. Metastatic HCC was only
apparent on histology examination of the right atrial
tumor. Metastatic disease as the initial presentation of
HCC appears in less than 5% of cases [5]. In addition
histological investigation defines whether the mass
Figure 1 CT angiogram verifying the presence of a mass inside
the right atrium occupying almost the whole cavity.
Figure 2 The right atrium incised and the exposed tumor.
Figure 3 The tumor specimen.
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pic one with no liver involvement.
Regarding the symptoms, there is a variety of clinical
manifestations caused by the atrial neoplasm and those
are mainly tumor-size dependent. Patients may have no
symptoms, dyspnea due to pulmonary embolism, syn-
cope, or heart failure. Physical findings include edema,
pan systolic murmur with diastolic rumble over the tri-
cuspid valve, and improvement of symptoms with left
lateral decubitus position [6].
Extracardiac tumours involving inferior vena cava and
right atrium include renal cell tumour (4-10%) [7], thyr-
oid carcinoma, testicular tumours and HCC. In most
cases of advanced HCC the extent of the disease is veri-
fied with presence of metastasis at the lungs, peritoneum,
adrenal glands and bones. Generally hepatocellular carci-
noma appears to have a tendency to invade vascular
structures [8]. Extension to the portal vein system is
common as opposed to extension into the inferior vena
cava or the right atrium which is uncommon [2]. When
this occurs, it mostly happens through the hepatic veins
and the inferior vena cava towards the right atrium. A
right atrial intracavitary ma s si st h e nf o r m a t t e dw h i c h
causes significant hemodynamic instability. In addition,
left atrium, right ventricle, and intramyocardial involve-
ment of the left ventricle have also been reported as rare
sites of HCC metastasis as well as spreading of the cancer
to the left chambers through pulmonary metastasis or
patent foramen ovale [9].
Regarding the case described here, the appearance of a
metastatic HCC tumor inside the right atrium as the
only manifestation and without apparent primary focus
is unique. The chest CT angiography was the most
important diagnostic modality in this case. It was very
helpful in identifying the borders of the tumor. There
are various sub diaphragmatic tumors including renal
cell tumors and HCC which extend from below the dia-
phragm up to the right chambers of the heart either
through the venous system or through diaphragm inva-
sion. It is important to know the tumor location before
bicaval cannulation to prevent fragmentation and embo-
lisation of the tumor. The understanding that the tumor
was well confined inside the right atrium was important
for the correct planning of the procedure. CT angio-
gram allowed for correct placement of the arterial and
venous cannulas. Thus, the arterial and one venous can-
nula were placed inside the femoral vessels and the uti-
lity of femoro femoral by pass circuit allowed opening
of the chest with optimal safety. The other venous can-
nula was placed inside the superior vena cava. The right
atrium was left without any cannulas in order to avoid
any contact with the friable mass and minimise the risk
for pulmonary embolism [10].
Intra atrial manifestation of the HCC constitutes a life
threatening condition. The major causes of death are
either sudden pulmonary embolism of the thrombus or
acute obstruction of the tricuspid valve or both. Resec-
tion can provide relatively good mid-term survival
regarding this clinical situation but not more than 2
years [11]. Standard treatment is hepatic resection with
removal of the intracardial mass usually under cardiopul-
monary bypass with deep hypothermia and circulatory
arrest which seems to be the optimal option in most
cases. A few reports describe the successful removal of
HCC from the right atrium without extracorporeal circu-
lation as an alternative [12]. However, both curative
resection treatments have a dismal prognosis, with a 5
years reported survival around 12-39% [3].
After resection of a hepatocellular carcinoma, tumour
recurrence exceeds up to 70% at 5 years, including
recurrence due to dissemination and de novo tumours
of the liver. The most important statistically predictor of
recurrence seems to be the presence of micro vascular
invasion and/or additional tumour sites besides the pri-
mary lesion [13]. There is no effective adjuvant therapy
that can reduce the recurrence rates. (Recommendation
level II) [13,14]
Internal radiation and adoptive immunotherapy by
activated lymphocytes may have some anti-tumor efficacy
but the early results have not been statistically powered
as yet [15]. There are no adequate published data to indi-
cate proper treatment of recurrences. Solitary recurrent
masses might benefit from repeat resection but in the
majority of cases recurrence appears to be multifocal and
so further treatment is impossible [13].
Conclusion
In conclusion, when a patient with a history of chronic
hepatic disease presents with symptoms of right heart
failure one must be cautious and should bear in mind
that right heart involvement from a malignant tumour
may be present [16]. Echocardiography computed tomo-
graphy and magnetic resonance imaging are the stan-
dard imaging modalities to determine the nature of
tumors presented as secondary cardiac neoplasms
[16,17]. Urgent Computed tomography can easily and
quickly be performed prior to surgical treatment of
emergency cases. Ultrasound with liver-specific micro
bubbles and PET CT can be helpful in certain cases of
occult HCC [18,19].
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